Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Performance evaluation of the Abbott RealTime HCV Genotype II for hepatitis C virus genotyping.

Clinical chemistry and laboratory medicine - 1 Apr 2010

Sohn Yong-Hak, Ko Sun-Young, Kim Myeong Hee, Oh Heung-Bum

Abstract excerpt

BACKGROUND: The Abbott RealTime hepatitis C virus (HCV) Genotype II (Abbott Molecular Inc.) for HCV genotyping, which uses real-time PCR technology, has recently been developed. METHODS: Accuracy and sensitivity of detection were assessed using the HCV RNA PHW202 performance panel (SeraCare Life Sciences). Consistency with restriction fragment mass polymorphism (RFMP) data, cross-reactivity with other viruses,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genotype
Share to Hepacivirus
Share to Hepatitis C

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Polymerase Chain Reaction

Share to Reagent Kits, Diagnostic

Share to RNA, Viral

Source

Identifiers

PMID: 20128734
DOI: 10.1515/CCLM.2010.093

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Performance evaluation of the Abbott RealTime HCV Genotype II for hepatitis C virus genotyping.PMID 20128734Read ↗

Comparison of diagnostic performance among Abbott RealTime HCV Genotyping II, Abbott HCV Genotype plus RUO, and Roche Cobas HCV Genotyping assays for hepatitis C virus genotyping.Semantic proximity Read ↗

[Hepatitis C virus genotyping: comparison of the Abbott RealTime HCV Genotype II assay and NS5B sequencing].Semantic proximity Read ↗

The need for a sequencing-based assay to supplement the Abbott m2000 RealTime HCV Genotype II assay: a 1 year analysis.Semantic proximity Read ↗

Evaluation of the Abbott investigational use only RealTime hepatitis C virus (HCV) assay and comparison to the Roche TaqMan HCV analyte-specific reagent assay.Semantic proximity Read ↗

Infection with multiple hepatitis C virus genotypes detected using commercial tests should be confirmed using next generation sequencingSemantic proximity Read ↗

Comparison of Abbott RealTime HCV Genotype II with Versant Line Probe Assay 2.0 for Hepatitis C Virus GenotypingSemantic proximity Read ↗

Multiplex real-time reverse transcription-PCR assay for determination of hepatitis C virus genotypes.Semantic proximity Read ↗

Performance of the Abbott Real-Time PCR Assay Usingm2000spandm2000rtfor Hepatitis C Virus RNA QuantificationSemantic proximity Read ↗

Performance of the Abbott RealTime and Roche Cobas TaqMan hepatitis C virus (HCV) assays for quantification of HCV genotypes.Semantic proximity Read ↗

Utility of the Abbott RealTime HCV Genotype Plus RUO assay used in combination with the Abbott RealTime HCV Genotype II assay.Semantic proximity Read ↗

A multicenter evaluation of the Abbott RealTime HCV Genotype II assay.Semantic proximity Read ↗

Accuracy of a commercially available assay for HCV genotyping and subtyping in the clinical practice.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.